Innovation in Personalized Medicine & Population Health Speaker Series

Multi-cancer Early Detection (MCED) assays represent a  new paradigm in cancer screening with the potential to deliver on the long-unfulfilled promise of earlier detention of many cancers with a single test. However, introducing such technology at scale has the potential to create new challenges for patients, providers, and health systems. In this session we will explore ways to translate technology into action and build your organizations' tool box.